AG
KZR

Algert Global’s Kezar Life Sciences KZR Stock Holding History

Algert Global’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,739
Closed -$68K – 1194
2023
Q3 		$68K Hold
5,739
– – ﹤0.01% 1052
2023
Q2 		$141K Sell
5,739
-1,485
-21% -$38.7K 0.01% 1013
2023
Q1 		$226K Buy
7,224
+217
+3% +$12.6K 0.01% 1005
2022
Q4 		$493K Buy
7,007
+3,336
+91% +$247K 0.03% 806
2022
Q3 		$316K Buy
+3,671
New +$357K 0.02% 938

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Algert Global's KZR Position: Q4 2023 in Review

Algert Global sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 5,739 shares — an estimated $68K sold.

Algert Global first reported a position in KZR in Q3 2022 and held it in 5 quarters. The position peaked at $493K in Q4 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Algert Global reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 5,739 Kezar Life Sciences shares in Q4 2023, an estimated $68K.
  • Algert Global first reported a position in Kezar Life Sciences in Q3 2022 and held it in 5 quarters.
  • Algert Global's Kezar Life Sciences position peaked at $493K in Q4 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.